Steven de Maat

1.9k total citations
42 papers, 1.3k citations indexed

About

Steven de Maat is a scholar working on Genetics, Hematology and Immunology. According to data from OpenAlex, Steven de Maat has authored 42 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Genetics, 26 papers in Hematology and 13 papers in Immunology. Recurrent topics in Steven de Maat's work include Coagulation, Bradykinin, Polyphosphates, and Angioedema (27 papers), Blood Coagulation and Thrombosis Mechanisms (22 papers) and Platelet Disorders and Treatments (9 papers). Steven de Maat is often cited by papers focused on Coagulation, Bradykinin, Polyphosphates, and Angioedema (27 papers), Blood Coagulation and Thrombosis Mechanisms (22 papers) and Platelet Disorders and Treatments (9 papers). Steven de Maat collaborates with scholars based in Netherlands, Germany and Belgium. Steven de Maat's co-authors include Coen Maas, Zonne L. M. Hofman, Thomas Renné, C. Erik Hack, Philip G. de Groot, Gerard Pasterkamp, Jenny Björkqvist, Claudia Tersteeg, Arjan D. Barendrecht and Philip de Groot and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Steven de Maat

42 papers receiving 1.2k citations

Peers

Countries citing papers authored by Steven de Maat

Since Specialization

Citations

This map shows the geographic impact of Steven de Maat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven de Maat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven de Maat more than expected).

Fields of papers citing papers by Steven de Maat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven de Maat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven de Maat. The network helps show where Steven de Maat may publish in the future.

Co-authorship network of co-authors of Steven de Maat

This figure shows the co-authorship network connecting the top 25 collaborators of Steven de Maat. A scholar is included among the top collaborators of Steven de Maat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven de Maat. Steven de Maat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Plasmin-cleaved von Willebrand factor as a biomarker for microvascular thrombosis 2024 ·Blood ·(unknown), (unknown), Simone M. Smits, Arjan D. Barendrecht, Steven de Maat, Rob Fijnheer, Peter J. Lenting, Claudia Tersteeg	4
2	Plasmin-Cleaved Von Willebrand Factor As a Biomarker for Microvascular Thrombosis 2023 ·Blood ·(unknown), (unknown), Simone M. Smits, Steven de Maat, Rob Fijnheer, Arjan D. Barendrecht, Peter J. Lenting, Claudia Tersteeg	2
3	VWF-targeted thrombolysis to overcome rh-tPA resistance in experimental murine ischemic stroke models 2022 ·Blood ·(unknown), Steven de Maat, (unknown), (unknown), (unknown), Thomas Bonnard, Denis Vivien, H. Bart van der Worp, Rick M. Dijkhuizen, Coen Maas	12
4	Directing HIV-1 for degradation by non-target cells, using bi-specific single-chain llama antibodies 2022 ·Scientific Reports ·Jord C. Stam, Steven de Maat, Dorien de Jong, (unknown), (unknown), Lavina Gharu, Mark H. van Roosmalen, Rob C. Roovers, Nika M. Strokappe, Ralf Wagner, (unknown), Hans J. de Haard, Paul M.P. van Bergen en Henegouwen, Monique Nijhuis, C. Theo Verrips	2
5	Blood Clotting and the Pathogenesis of Types I and II Hereditary Angioedema 2021 ·Clinical Reviews in Allergy & Immunology ·Steven de Maat, Kusumam Joseph, Coen Maas, Allen P. Kaplan	17
6	Targeted SERPIN (TaSER): A dual‐action antithrombotic agent that targets platelets for SERPIN delivery 2021 ·Journal of Thrombosis and Haemostasis ·(unknown), Simone M. Smits, Arjan D. Barendrecht, (unknown), (unknown), (unknown), Mark Roest, Thomas Renné, (unknown), Steven de Maat, Coen Maas	6
7	Microlyse: a thrombolytic agent that targets VWF for clearance of microvascular thrombosis 2021 ·Blood ·Steven de Maat, (unknown), Arjan D. Barendrecht, Simone M. Smits, (unknown), (unknown), (unknown), (unknown), Michael Szardenings, Nicolas Delaroque, (unknown), Rolf T. Urbanus, Silvie Sebastian, Peter J. Lenting, Christoph E. Hagemeyer, Thomas Renné, Karen Vanhoorelbeke, Claudia Tersteeg, Coen Maas	17
8	A reactive center loop–based prediction platform to enhance the design of therapeutic SERPINs 2021 ·Proceedings of the National Academy of Sciences ·(unknown), (unknown), Simone M. Smits, (unknown), Marcel H.A.M. Fens, Peter J. Lenting, Coen Maas, Steven de Maat	9
9	Cold-induced urticarial autoinflammatory syndrome related to factor XII activation 2020 ·Nature Communications ·Jörg Scheffel, (unknown), Zonne L. M. Hofman, Steven de Maat, Jim S. Wu, Hanna Bonnekoh, Reuben J. Pengelly, Sarah Ennis, John W. Holloway, Marieluise Kirchner, Philipp Mertins, Martin K. Church, Marcus Maurer, Coen Maas, Karoline Krause	31
10	Design and characterization of α1-antitrypsin variants for treatment of contact system–driven thromboinflammation 2019 ·Blood ·Steven de Maat, (unknown), Reiner K. Mailer, (unknown), Martin Hessing, (unknown), Joost C.M. Meijers, Gerard Pasterkamp, Thomas Renné, Coen Maas	20
11	Heparin Forms Polymers with Cell-free DNA Which Elongate Under Shear in Flowing Blood 2019 ·Scientific Reports ·(unknown), Arjan D. Barendrecht, (unknown), Rolf T. Urbanus, Péter Boross, Steven de Maat, Coen Maas	4
12	A mutation in the kringle domain of human factor XII that causes autoinflammation, disturbs zymogen quiescence, and accelerates activation 2019 ·Journal of Biological Chemistry ·Zonne L. M. Hofman, (unknown), (unknown), (unknown), (unknown), (unknown), Karoline Krause, (unknown), Jörg Scheffel, C. Erik Hack, Marcus Maurer, Steven de Maat, Coen Maas	19
13	Factor XII truncation accelerates activation in solution 2018 ·Journal of Thrombosis and Haemostasis ·Steven de Maat, (unknown), (unknown), (unknown), (unknown), Zonne L. M. Hofman, Coen Maas	24
14	Hereditary angioedema: the plasma contact system out of control 2018 ·Journal of Thrombosis and Haemostasis ·Steven de Maat, Zonne L. M. Hofman, Coen Maas	59
15	Virulence Associated Gene 8 of Bordetella pertussis Enhances Contact System Activity by Inhibiting the Regulatory Function of Complement Regulator C1 Inhibitor 2018 ·Frontiers in Immunology ·Elise S. Hovingh, Steven de Maat, (unknown), Steven Johnson, Elena Pinelli, Coen Maas, Ilse Jongerius	6
16	Polyphosphate nanoparticles on the platelet surface trigger contact system activation 2017 ·Blood ·J. Verhoef, Arjan D. Barendrecht, Katrin F. Nickel, (unknown), Ellinor Kenne, Linda Labberton, Owen J. T. McCarty, Raymond M. Schiffelers, Harry F.G. Heijnen, Antoni P. A. Hendrickx, Huub Schellekens, Marcel H.A.M. Fens, Steven de Maat, Thomas Renné, Coen Maas	123
17	High‐molecular‐weight kininogen: breaking bad in lethal endotoxemia 2017 ·Journal of Thrombosis and Haemostasis ·Zonne L. M. Hofman, Steven de Maat, Coen Maas	5
18	Factor XII: form determines function 2016 ·Journal of Thrombosis and Haemostasis ·Steven de Maat, Coen Maas	67
19	Plasmin is a natural trigger for bradykinin production in patients with hereditary angioedema with factor XII mutations 2016 ·Journal of Allergy and Clinical Immunology ·Steven de Maat, Jenny Björkqvist, Chiara Suffritti, (unknown), (unknown), Arnold C. Koekman, (unknown), Gerard Pasterkamp, Philip G. de Groot, Marco Cicardi, Thomas Renné, Coen Maas	123
20	A nanobody-based method for tracking factor XII activation in plasma 2013 ·Thrombosis and Haemostasis ·Steven de Maat, (unknown), Philip G. de Groot, Coen Maas	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact